Ban of Butylphenyl Methylpropional Postponed in the UK
Due to its classification as toxic to reproduction (Repr.1B - CMR 1B), Butylphenyl Methylpropional is now prohibited in cosmetic products in the European Union. Currently, this ingredient can still be used (subject to restrictons) in cosmetics marketed in Great Britain. However, a ban on Butylphenyl Methylpropional is expected in the near future in GB.

BUTYLPHENYL METHYLPROPIONAL

Butylphenyl Methylpropional, commonly known as Lilial (main trade name) or p-BMHCA, is an aromatic aldehyde, a synthetic fragrance ingredient that has been used for years in different types of cosmetics and personal care products. Butylphenyl Methylpropional is also used in several non-cosmetic products, like household cleaners and detergents.

Opinions issued by the European Commission’s Scientific Committee on Consumer Safety (SCCS) have expressed concern about this ingredient (risk of skin sensitization, aggregate exposure). Butylphenyl Methylpropional as a net compound revealed to be irritating to the skin and eyes of rabbits. Moreover, this ingredient poses a risk of inducing skin sensitization in humans. (see previous post)

BUTYLPHENYL METHYLPROPIONAL PROHIBITED IN COSMETIC PRODUCTS IN THE EU

In May 2020, the European Commission published the Commission Delegated Regulation No. 2020/1182, regarding the classification, labelling and packaging of substances and mixtures (amendment to CLP Regulation (EC) No. 1272/2008). In accordance with this amendment to the CLP Regulation, Butylphenyl Methylpropional is now classified as Repr. 1B (toxic to reproduction – CMR 1B), applying from 1st of March 2022. (see previous post)

According to the European Cosmetic Regulation ((EC) No 1223/2009), the use of substances classified as CMR (carcinogenic, mutagenic or toxic to reproduction, under the CLP Regulation) is banned.

As of March 1, 2022, Butylphenyl Methylpropional can no longer be used in cosmetic products marketed in the European Union (EU). This ingredient is currently included in list of the substances prohibited in cosmetic products (Annex II, entry 1666) of the European Cosmetics Regulation (No 1223/2009).

This applies to all cosmetic products, both new cosmetics and products already placed on the market. Since the beggining of this month, all products containing Butylphenyl Methylpropional must be off shelves!

BUTYLPHENYL METHYLPROPIONAL IN THE UK

Cosmetic products placed on the Great Britain (GB – England, Wales and Scotland) market must comply with Schedule 34 of the Product Safety and Metrology Statutory Instrument (UK Cosmetics Regulation). (see previous post)

On 14th February, the Cosmetic, Toiletry & Perfumery Association (CTPA), which represents all types of companies involved in making, supplying and selling cosmetic and personal care products in the UK, published a public statement regarding the legal status of Butylphenyl Methylpropional in GB.

CTPA clarifies that “the legal status of BMHCA/Lilial in GB is different from that in the EU/NI, as different legislations are applicable in the two markets. CTPA expects a ban on BMHCA/Lilial to come into force in GB in the near future“.

At the moment, Butylphenyl Methylpropional is a restricted fragrance allergen (included in Annex III) and can still be used in cosmetic products marketed in GB. A ban was not published yet, but it is expected in the future.

If you wish to get more information regarding this or other subjects, feel free to contact us at info@criticalcatalyst.com.

References:

  1. Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products. 
  2. Commission Delegated Regulation (EU) No. 2020/1182 of 19 May 2020 amending, for the purposes of its adaptation to technical and scientific progress, Part 3 of Annex VI to Regulation (EC) No. 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures.
  3. The Product Safety and Metrology etc. (Amendment etc.) (EU Exit) Regulations 2019, Schedule 34 – Amendment of Regulation (EC) No 1223/2009 and related amendments. 
  4. CTPA Public Statement on the Legal Status of BMHCA/Lilial in GB. Available from: https://www.ctpa.org.uk/news/ctpa-public-statement-on-the-legal-status-of-bmhcalilial-in-gb-5852

further
reading

cosmetic products

Citral under review: SCCS Preliminary Opinion

The SCCS was tasked by the European Commission to evaluate if the safety levels for Citral, determined through QRA2 based on skin sensitization induction, are sufficient to safeguard consumers. A preliminary opinion was released.

Read More »
cosmetic products

Are sunscreens with Benzophenone-4 safe?

Benzophenone-4 is commonly known as a UV-filter in cosmetic products. Learn what the final opinion of SCCS states about Benzophenone’s safety profile as a UV-filter in cosmetic products.

Read More »
cosmetic products

Is Aluminium in cosmetics safe for human health?

The Scientific Committee on Consumer Safety (SCCS) published its Final Opinion on the safety of Aluminium in cosmetic products. This follows a lengthy review process that began in 2013 when the SCCS was first mandated to evaluate the potential health risks of Aluminium (Al) and its compounds in cosmetics.

Read More »
cosmetic products

Silver in Cosmetics: SCCS preliminary opinion.

Ingredients: SILVER

The recent preliminary opinion from the Scientific Committee on Consumer Safety (SCCS) regarding silver in cosmetics is crucial for consumers and manufacturers. This article breaks down the key points, making it easier to understand the implications and stay informed.

Read More »
news & updates

EU Ecolabel adoption and recognition are on the rise

The Ecolabel certification is a comprehensive program focused on fostering sustainable practices. It evaluates products based on life cycle assessments, where every phase of said life cycle must abide by strict standards to attain the Ecolabel certification. The overarching objective of this certification is minimizing environmental harm from production or consumption activities.

Read More »
cosmetic products

UK proposes ban of wet wipes containing plastic 

The UK has proposed, on April 24, 2024, a regulation titled The Environmental Protection (Wet Wipes Containing Plastic) (England) Regulations 2024, to the World Trade Organization (WTO). The regulation aims to eliminate the supply and sale of plastic-containing wet wipes, including cosmetic ones. The public can offer comments on the draft until June 23, 2024, with adoption expected in September of the same year.

Read More »
news & updates

SCCS preliminary opinion on Citral sensitization endpoint

Ingredients: CITRAL

Date of publication: 27/03/2024

On March 27 2024, the Scientific Committee on Consumer Safety (SCCS) published the Preliminary Opinion on the safety of Citral in cosmetic products. The deadline for comments is set to June 2, 2024.

Read More »
medical devices

Safety Reporting in Clinical Investigations: a Gap Analysis of Guidance Documents 

Safety reporting in clinical investigations of medical devices shall be performed in line with Article 80(2) of the EU MDR. On May 2020, it was published the MDCG 2020-10/1, outlining the procedures for safety reporting in clinical investigations of medical devices under the EU MDR. However, on October 2022 the Medical Device Coordination Group (MDCG) published an updated version of the MDCG 2020-10/1, the MDCG 2020-10/1 Rev 1. This article highlights the updates included in the new revision, analysing the gaps between both documents.

Read More »
medical devices

Roles and Responsibilities of an Authorised Representative under EU MDR and IVDR 

If a medical device manufacturer is not established in a Member State, the devices can only be placed on the Union market if the manufacturer designates an authorised representative. The authorised representative plays a pivotal role in ensuring the compliance of the devices with EU regulation, serving as point of contact. The obligations and responsibilities of authorised representative are outlined on Article 11 of both MDR and IVDR, but clarification of relevant requirements is described in MDCG 2022-16 of October 2022.

Read More »
medical devices

Understanding the ISO Standards Lifecycle

ISO Standards cover a huge range of activities, representing the distilled wisdom of people with expertise in their subject matter and providing the regulators with a sound basis to develop better legislation. ISO Standards are diverse, addressing from the shoe size we wear to the quality of air we breathe. The medical device sector is no exception. ISO has many International Standards and guidance documents aimed at helping the sector ensure safe and effective medical devices while meeting the multitude of national, regional and international regulatory requirements. But how exactly is a Standard developed, reviewed and withdraw?

Read More »